Diffusion-weighted imaging or MR spectroscopy: Which to use for the assessment of the response to chemotherapy in breast cancer patients?

• Published in: Egyptian journal of radiology and nuclear medicine 2021-08, Vol.52 (1), p.190-14
• Main Authors: Mansour, Sahar, Selim, Ashraf, Kassam, Loay, Adel, Mirna, Hashem, Aya Bassam
• Format: Article
• Language: English
• Subjects: Adjuvant treatment; Breast cancer; Cancer; Cancer therapies; Care and treatment; Chemotherapy; Choline; Diffusion-weighted MRI (DWI); Drunk driving; Edema; Health aspects; Histopathology; Lymphatic system; Magnetic resonance imaging; Medical research; Medicine, Experimental; Metastasis; MR spectroscopy (MRS); Neo-adjuvant chemotherapy; Pathologic complete remission; Pathology; Spectrum analysis; Tumors
• ISSN: 0378-603X; 2090-4762
• DOI: 10.1186/s43055-021-00574-2

Background Diffusion-weighted MRI (DWI) and MR spectroscopy (MRS) both are noninvasive MR sequences that could be used as a reliable tool to assess the functional behavior of the breast cancer. The aim of the study was to assess the value of DWI and MRS in predicting the early response to neo-adjuvant chemotherapy (NAC) and absence of residual disease after treatment. Results One hundred thirty-three patients diagnosed with breast cancer and scheduled for NAC were enrolled in this study. All lesions were subjected to qualitative and quantitative analysis of DCE-MRI, DWI and MRS, where the lesions size, kinetic parameters, ADC values and MRS choline peak were recorded before the start of NAC and after completion of chemotherapy. The results of each MRI modality were correlated with the findings that were found at the pathology report of the complete surgical specimen. The sensitivity and specificity of the MR modalities to predict pathological complete remission post-NAC were 73.68% and 83.33%, respectively, using the kinetic curve pattern, 78.95% and 83.33%, respectively, using the ADC value and finally 78.95% and 91.67%, respectively, using the MRS choline peak. Similar sensitivity (89.47%) to predict pathological complete remission was presented by the ADC value and the MRS choline peak together when compared to the ADC value and dynamic curve patterns. Conclusion DWI and MRS are valuable MRI techniques and their accuracy in detecting residual disease is almost similar to that of DCE MRI. The inclusion of these sequences in the imaging protocol of NAC candidates improve monitoring of the response to treatment and allow early distinction between complete, partial and non-responders' cases in breast cancer patients.